iTeos Therapeutics, Inc. Common Stock

ITOS US46565G1040

💰
Capitalization
Small-cap

ITeos Therapeutics Inc is a biopharmaceutical company. It designs novel product candidates with optimized pharmacologic properties to improve clinical outcomes by restoring the immune response against cancer. The company's product candidates include EOS-850 which is an Adenosine A2A receptor-specific antagonist, EOS-448 which is an ADCC-enabled, anti-TIGIT immune checkpoint blocking antibody among other drug candidates.

🔗
Website
https://www.iteostherapeutics.com
Annual Performance 1
2021 2022 2023 2024 2025
40% -59% -41% -34% 3%
Annual Insiders Turnover, USD 2

1 annual and historical performance metrics are recalculated on a daily basis;
2 represents the total value of insider transactions (both buying and selling);

Insider Activity
📊
Transactions
31
🙍
Insiders
4
Person Price Shares Total Published Completed
Detheux Michel
CEO 		10.02
USD 		43,883
Sold 		439,708
USD 		09/06/2025 10/06/2025
Detheux Michel
CEO 		10.02
USD 		8,400
Sold 		84,168
USD 		09/06/2025 10/06/2025
Detheux Michel
CEO 		10.02
USD 		8,400
Sold 		84,168
USD 		09/06/2025 10/06/2025
Detheux Michel
CEO 		10.02
USD 		43,883
Sold 		439,708
USD 		09/06/2025 10/06/2025
Detheux Michel
CEO 		10.03
USD 		8,400
Sold 		84,252
USD 		09/06/2025 09/06/2025
Detheux Michel
CEO 		10.03
USD 		43,882
Sold 		440,136
USD 		09/06/2025 09/06/2025
Detheux Michel
CEO 		10.03
USD 		43,882
Sold 		440,136
USD 		09/06/2025 09/06/2025
Detheux Michel
CEO 		10.03
USD 		8,400
Sold 		84,252
USD 		09/06/2025 09/06/2025
Hallal David
 10.24
USD 		38,228
Sold 		391,455
USD 		04/06/2025 06/06/2025
Detheux Michel
CEO 		10.21
USD 		8,400
Sold 		85,764
USD 		04/06/2025 06/06/2025

Integrated EOD Stock Data and Insider Transactions Chart

Sign in or subscribe to include iTeos Therapeutics, Inc. Common Stock to your watchlist and receive automatic alerts for upcoming transactions.

The visibility of insider buy and sell transactions on this chart should not be the sole factor in your decision to buy or sell a particular stock. Always consider the following dynamic reports for a broader understanding of stock market activities:

 

Historical Performance
1M 3M 6M 1Y 3Y 5Y All Time
-5% -54% -29% -37% -59% 0% -57%
Last 52W Low 52W High All-Time Low All-Time High β
10.15 5.04 10.35 5.04 47.86
Company Insiders
Person / Entity Transactions Turnover, USD Average, USD First Last
Ecor1 Capital, Llc 4 77,371,123.16 19,342,780.79 14/05/2025 15/05/2025
Detheux Michel 20 5,281,567.88 264,078.39 04/06/2025 10/06/2025
Hallal David 6 2,328,809.32 388,134.89 04/06/2025 06/06/2025
Gall Matthew 1 38,635.00 38,635.00 19/11/2024 19/11/2024

Insiders marked in yellow represent long-term insiders. These are individuals who have engaged in transactions for over 3 years and have conducted at least 10 transactions or reached a cumulative turnover of $1M USD. When examining transaction clusters, we prioritize those conducted by long-term insiders for analysis.

Stock Advanced Metrics
Delta Correlation subscribe 🔒
Upper Bound of Standardized Transaction Amount (ubsta), USD 4 subscribe 🔒

4 represents the maximum expected transaction amount for a company's insiders, calculated based on historical data. It provides insight into the typical range of insider transaction amounts and helps in identifying unusually large transactions.

5 a proprietary metric reflecting the consistency of insider trading behavior within a company. A higher discipline index suggests more regular and predictable insider transactions.